Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1996 Oct;104(Suppl 5):945–947. doi: 10.1289/ehp.96104s5945

Chronic beryllium disease: diagnosis and management.

M D Rossman 1
PMCID: PMC1469698  PMID: 8933039

Abstract

Chronic beryllium disease is predominantly a pulmonary granulomatosis that was originally described in 1946. Symptoms usually include dyspnea and cough. Fever, anorexia, and weight loss are common. Skin lesions are the most common extrathoracic manifestation. Granulomatous hepatitis, hypercalcemia, and kidney stones can also occur. Radiographic and physiologic abnormalities are similar to those in sarcoidosis. While traditionally the pathologic changes included granulomas and cellular interstitial changes, the hallmark of the disease today is the well-formed granuloma. Immunologic studies have demonstrated a cell-mediated response to beryllium that is due to an accumulation of CD4+ T cells at the site of disease activity. Diagnosis depends on the demonstration of pathologic changes (i.e., granuloma) and evidence that the granuloma was caused by a hypersensitivity to beryllium (i.e., positive lung proliferative response to beryllium). Using these criteria, the diagnosis of chronic beryllium disease can now be made before the onset of clinical symptoms. Whether, with early diagnosis, the natural course of this condition will be the same as when it was traditionally diagnosed is not known. Currently, corticosteroids are used to treat patients with significant symptoms or evidence of progressive disease.

Full text

PDF
945

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews J. L., Kazemi H., Hardy H. L. Patterns of lung dysfunction in chronic beryllium disease. Am Rev Respir Dis. 1969 Dec;100(6):791–800. doi: 10.1164/arrd.1969.100.6.791. [DOI] [PubMed] [Google Scholar]
  2. Aronchick J. M., Rossman M. D., Miller W. T. Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology. 1987 Jun;163(3):677–682. doi: 10.1148/radiology.163.3.3575713. [DOI] [PubMed] [Google Scholar]
  3. CURTIS G. H. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol. 1951 Oct;64(4):470–482. doi: 10.1001/archderm.1951.01570100087014. [DOI] [PubMed] [Google Scholar]
  4. Cullen M. R., Kominsky J. R., Rossman M. D., Cherniack M. G., Rankin J. A., Balmes J. R., Kern J. A., Daniele R. P., Palmer L., Naegel G. P. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume. Am Rev Respir Dis. 1987 Jan;135(1):201–208. doi: 10.1164/arrd.1987.135.1.201. [DOI] [PubMed] [Google Scholar]
  5. Deodhar S. D., Barna B., Van Ordstrand H. S. A study of the immunologic aspects of chronic berylliosis. Chest. 1973 Mar;63(3):309–313. doi: 10.1378/chest.63.3.309. [DOI] [PubMed] [Google Scholar]
  6. Epstein P. E., Dauber J. H., Rossman M. D., Daniele R. P. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med. 1982 Aug;97(2):213–216. doi: 10.7326/0003-4819-97-2-213. [DOI] [PubMed] [Google Scholar]
  7. Freiman D. G., Hardy H. L. Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Pathol. 1970 Mar;1(1):25–44. doi: 10.1016/s0046-8177(70)80003-x. [DOI] [PubMed] [Google Scholar]
  8. Hart B. A., Harmsen A. G., Low R. B., Emerson R. Biochemical, cytological, and histological alterations in rat lung following acute beryllium aerosol exposure. Toxicol Appl Pharmacol. 1984 Sep 30;75(3):454–465. doi: 10.1016/0041-008x(84)90182-0. [DOI] [PubMed] [Google Scholar]
  9. Kreiss K., Mroz M. M., Zhen B., Martyny J. W., Newman L. S. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):985–991. doi: 10.1164/ajrccm/148.4_Pt_1.985. [DOI] [PubMed] [Google Scholar]
  10. Kreiss K., Wasserman S., Mroz M. M., Newman L. S. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med. 1993 Mar;35(3):267–274. [PubMed] [Google Scholar]
  11. Kriebel D., Brain J. D., Sprince N. L., Kazemi H. The pulmonary toxicity of beryllium. Am Rev Respir Dis. 1988 Feb;137(2):464–473. doi: 10.1164/ajrccm/137.2.464. [DOI] [PubMed] [Google Scholar]
  12. Marx J. J., Jr, Burrell R. Delayed hypersensitivity to beryllium compounds. J Immunol. 1973 Aug;111(2):590–598. [PubMed] [Google Scholar]
  13. Newman L. S., Bobka C., Schumacher B., Daniloff E., Zhen B., Mroz M. M., King T. E., Jr Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med. 1994 Jul;150(1):135–142. doi: 10.1164/ajrccm.150.1.8025739. [DOI] [PubMed] [Google Scholar]
  14. Newman L. S., Buschman D. L., Newell J. D., Jr, Lynch D. A. Beryllium disease: assessment with CT. Radiology. 1994 Mar;190(3):835–840. doi: 10.1148/radiology.190.3.8115636. [DOI] [PubMed] [Google Scholar]
  15. Rossman M. D., Kern J. A., Elias J. A., Cullen M. R., Epstein P. E., Preuss O. P., Markham T. N., Daniele R. P. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med. 1988 May;108(5):687–693. doi: 10.7326/0003-4819-108-5-687. [DOI] [PubMed] [Google Scholar]
  16. Saltini C., Winestock K., Kirby M., Pinkston P., Crystal R. G. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989 Apr 27;320(17):1103–1109. doi: 10.1056/NEJM198904273201702. [DOI] [PubMed] [Google Scholar]
  17. Stoeckle J. D., Hardy H. L., Weber A. L. Chronic beryllium disease. Long-term follow-up of sixty cases and selective review of the literature. Am J Med. 1969 Apr;46(4):545–561. doi: 10.1016/0002-9343(69)90074-6. [DOI] [PubMed] [Google Scholar]
  18. Williams W. J., Wallach E. R. Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis and other granulomatous diseases. Sarcoidosis. 1989 Sep;6(2):111–117. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES